NeurogesX and Astellas Enter Commercialization Agreement for Qutenza(TM)
San Mateo, California and Staines, England (ots/PRNewswire) – – Conference Call Today at 9:00am ET - Covers Europe, Middle East and Africa - Includes Licensing Option and Development Funding for...
View ArticleBoehringer Ingelheim Receives Positive Recommendation From European...
Ingelheim, Germany (ots/PRNewswire) – – For non-U.S. Healthcare Media Boehringer Ingelheim announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines...
View ArticleOnglyza(R) (saxagliptin) Receives Marketing Authorisation in Europe for the...
Paris and London (ots/PRNewswire) – Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN) (LSE: AZN) announced today that the European Commission has granted marketing authorisation for...
View ArticleBARACLUDE(R) (entecavir) Approved by the European Commission for the...
Paris (ots/PRNewswire) – Bristol-Myers Squibb announced today that BARACLUDE(R) (entecavir) has been approved by the European Commission on February 28th 2011 to treat chronic hepatitis B (CHB) in...
View ArticleEANS-News: CE mark granted for wound spray based on Sangui patent
——————————————————————————– Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. ——————————————————————————– Patents, Copyright...
View ArticleEANS-News: Sangui Bio Tech International Inc. / SastoMed starts Granulox...
——————————————————————————– Corporate news transmitted by euro adhoc. The issuer/originator is solely responsible for the content of this announcement. ——————————————————————————– Company...
View Article
